Design of Lipid-Based Formulations for Oral Administration of Poorly Water-Soluble Drug Fenofibrate: Effects of Digestion

Abstract

Abstract. Lipid-based drug carriers are likely to have influence on bioavailability through enhanced solubilization of the drug in the gastrointestinal tract. The study was designed to investigate the lipid formulation digestibility in the simulated gastro intestinal media. Fenofibrate was formulated in representative Type II, IIIA, IIIB and IV selfemulsifying/microemulsifying lipid delivery systems (SEDDS and SMEDDS designed for oral administration) using various medium-chain glyceride components, non-ionic surfactants and cosolvents as excipients. Soybean oil was used only as an example of long-chain triglycerides to compare the effects of formulation with their counterparts. The formulations were subjected to in vitro digestion specifically to predict the fate of the drug in the gastro intestinal tract after exposure of the formulation to pancreatic enzymes and bile. In vitro digestion experiments were carried out using a pH-stat maintained at pH 7.5 for 30 min using intestinal fluids simulating the fed and fasted states. The digestion rate was faster and almost completed in Type II and IIIA systems. Most of the surfactants used in the studies are digestible. However, the high concentration of surfactant and/or cosolvent used in Type IIIB or IV systems lowered the rate of digestion. The digestion of medium-chain triglycerides was faster than long-chain triglycerides, but kept comparatively less drug in the post digestion products. Medium-chain mixed glycerides are good solvents for fenofibrate as rapidly digested but to improve fenofibrate concentration in post digestion products the use of long-chain mixed glycerides are suggested for further investigations.KEY WORDS: fenofibrate; in vitro lipolysis; lipid formulation classification system; self-emulsifying/ microemulsifying drug delivery systems (SEDDS, SMEDDS).

The influence of bariatric surgery on oral drug bioavailability in patients with obesity: A systematic review

“…Fenofibrate and posaconazole, two model compounds belonging to the BCS class II (high permeability, low solubility), were studied on the basis of their absorption characteristics before and after RYGBP . To investigate the consequence of delayed contact with bile salts after surgery, fenofibrate can be used as a model drug because its solubility is highly dependent on bile salt concentrations, while posaconazole dissolution is pH dependent and can thus be used to indicate the effect of increased gastric pH following surgery . The results showed that the disposition of fenofibrate remained unaltered, whereas the exposure of posaconazole was reduced following surgery .…”

Novel dietary lipid-based self-nanoemulsifying drug delivery systems of paclitaxel with p-gp inhibitor: implications on cytotoxicity and biopharmaceutical performance

“…PUFA-rich dietary lipids are reported to be effective in circumnavigating the hepatic first-pass metabolism and augmenting the oral drug absorption through lymphatic pathways [39]. Labrasol, as a non-ionic water dispersible surfactant, tend to improve the oral absorption by increasing the membrane fluidity and by opening the tight junctions to facilitate transcellular and paracellular absorption of PTX, while addition of sodium deoxycholate stimulates the lipolysis of triglycerides in the SNEDDS to liberate chylomicrons for faster permeation and absorption of PTX through a mesenteric lymph duct into the systemic circulation [51]. The results obtained from the current studies vouch the utility of SNEDDS as one of the promising platform drug delivery technologies in augmenting the absorption of PTX through an oral route.…”

Development and validation of a UPLC method for quantification of antiviral agent, Acyclovir in lipid-based formulations

“…Within the scope of the current project, the developed UPLC method has been proposed for the quantification of ACV compound in the studies of equilibrium solubility, dynamic dispersion and dissolution profiles of lipid-based formulations (Mohsin, 2012). A dispersion profile is shown in Fig.…”